Lack Of Funding Takes Major Toll On Ebola Response 01/05/2019 Divya Schlesinger A festering civil conflict fueling rampant fear and distrust has been a major obstacle in the World Health Organization’s efforts to end the Ebola outbreak in the Democratic Republic of Congo (DRC). But now, funding shortages could further cripple the already strained response – unless the global community steps up quickly, Director-General Dr Tedros Adhanom […] Continue reading -> New Study Maps Vaccine Coverage Disparities, Helps Explain Why Targets Are Being Missed 26/04/2019 Maina Waruru Child vaccination targets of at least 80 percent coverage in low- and middle-income countries, are regularly being missed. To better understand why this is happening, a new study created high resolution maps of vaccine coverage to identify disparities within countries and to inform effective strategies to increase coverage and access. Image Credits: WHO. Continue reading -> Stepping Up The Fight Against Severe Malaria In Zambia: An Innovative Approach Scales Up 25/04/2019 David Branigan As leaders from across the globe met in Paris today to renew commitments against malaria on World Malaria Day, a Geneva-based group announced the scale-up of a project in rural Zambia that reduced severe malaria fatality by 96 percent. The innovative project administers life-saving drugs to children with malaria in rural communities, and provides immediate […] Continue reading -> Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
New Study Maps Vaccine Coverage Disparities, Helps Explain Why Targets Are Being Missed 26/04/2019 Maina Waruru Child vaccination targets of at least 80 percent coverage in low- and middle-income countries, are regularly being missed. To better understand why this is happening, a new study created high resolution maps of vaccine coverage to identify disparities within countries and to inform effective strategies to increase coverage and access. Image Credits: WHO. Continue reading -> Stepping Up The Fight Against Severe Malaria In Zambia: An Innovative Approach Scales Up 25/04/2019 David Branigan As leaders from across the globe met in Paris today to renew commitments against malaria on World Malaria Day, a Geneva-based group announced the scale-up of a project in rural Zambia that reduced severe malaria fatality by 96 percent. The innovative project administers life-saving drugs to children with malaria in rural communities, and provides immediate […] Continue reading -> Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
Stepping Up The Fight Against Severe Malaria In Zambia: An Innovative Approach Scales Up 25/04/2019 David Branigan As leaders from across the globe met in Paris today to renew commitments against malaria on World Malaria Day, a Geneva-based group announced the scale-up of a project in rural Zambia that reduced severe malaria fatality by 96 percent. The innovative project administers life-saving drugs to children with malaria in rural communities, and provides immediate […] Continue reading -> Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts
Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts